Rigel pharmaceuticals inc (RIGL)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Total revenues

102,425

59,288

48,753

29,683

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenues from collaborations

-

-

-

-

-

-

-

-

-

-

7,484

0

18,938

-

25,920

35,156

31,746

28,895

0

0

0

-

-

-

-

-

-

0

-

2,250

2,250

6,605

5,500

4,750

77,032

122,134

0

0

0

Total revenues

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Cost of product sales

954

906

797

517

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

58,085

52,885

52,405

49,039

46,610

46,903

44,697

44,408

45,135

46,269

46,342

51,705

57,649

63,446

68,375

67,705

65,296

62,825

60,875

61,525

66,529

67,696

71,129

72,552

71,882

75,328

77,046

79,658

81,189

78,778

78,833

75,963

72,148

69,350

65,925

0

0

0

-

Selling, general and administrative

73,072

74,588

77,646

77,594

76,456

70,002

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

General and administrative

-

-

-

-

-

-

-

-

-

-

30,330

26,941

23,895

-

18,476

18,194

17,519

17,813

19,795

20,408

21,702

22,501

20,446

20,234

19,733

19,612

20,816

21,522

22,088

22,849

23,088

22,785

22,170

21,768

21,207

21,791

0

0

0

Restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total costs and expenses

132,111

128,379

130,967

127,308

123,460

117,192

108,082

97,602

89,048

84,100

76,672

84,416

87,314

90,124

92,621

85,899

82,815

80,638

89,972

91,235

97,533

99,499

91,575

94,465

93,294

96,619

99,541

101,180

103,277

101,627

101,921

98,748

94,318

91,118

87,132

87,215

0

0

0

Income (Loss) from operations

-29,686

-69,091

-49,222

-61,555

-66,327

-72,683

-101,430

-94,915

-88,148

-79,616

-69,188

-74,072

-68,376

-69,741

-66,701

-50,743

-51,069

-51,743

-61,364

-75,623

-87,105

-91,249

-85,825

-88,715

-86,144

-89,469

-98,141

-99,780

-101,777

-99,377

-99,671

-92,143

-88,818

-86,368

-10,100

34,919

0

0

0

Interest income

2,110

2,532

2,764

2,813

2,634

2,203

1,851

1,442

1,085

892

657

572

490

437

386

330

277

222

206

206

209

243

268

320

372

426

486

493

520

520

519

520

466

420

384

346

0

0

0

Interest expense

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

37

58

0

0

0

Gain on disposal of assets

-

-

-

-

-

-

-

-

-

732

0

0

0

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss)

-28,053

-66,894

-46,466

-58,742

-63,693

-70,480

-99,579

-93,473

-87,063

-77,992

-67,711

-72,680

-67,066

-69,216

-66,313

-50,356

-50,735

-51,464

-61,049

-75,319

-86,798

-90,908

-85,497

-88,379

-85,756

-89,027

-97,638

-99,270

-101,240

-98,840

-99,155

-91,630

-88,366

-85,973

-9,753

0

0

0

-

Net income (loss) per share, basic and diluted
Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Basic (in dollars per share)

0.13

-

-

-

-0.11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.25

-0.37

-

0.97

0.52

Diluted (in dollars per share)

0.13

-

-

-

-0.11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.25

-0.37

-

0.96

0.51

Weighted average shares used in computing net income (loss) per share
Basic (in shares)

168,469

-

-

-

167,173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71,226

58,272

52,275

52,127

51,974

Diluted (in shares)

168,568

-

-

-

167,173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71,226

58,272

52,275

52,769

52,511

Net loss per share, basic and diluted (in dollars per share)

-

-

-0.07

-0.12

-

0.03

-0.14

-0.16

-0.17

-0.19

-0.14

-0.16

-0.13

-0.15

-0.24

-0.15

-0.19

-0.13

-0.08

-0.16

-0.21

-0.26

-0.24

-0.29

-0.25

-0.20

-0.27

-0.26

-0.29

-0.29

-0.36

-0.35

-0.32

-

-

-

-0.40

-

-

Weighted average shares used in computing net income (loss) per share, basic and diluted (in shares)

168,469

167,627

167,609

167,191

167,173

166,961

166,464

161,577

147,114

144,570

124,628

122,500

113,598

99,044

95,454

92,495

90,555

89,050

88,506

88,137

88,043

87,797

87,793

87,532

87,526

87,434

87,430

87,147

87,141

85,352

71,636

71,458

71,422

-

-

-

-

-

-

Product sales, net
Total revenues

48,398

43,772

34,808

24,879

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenues from collaborations
Total revenues

54,027

15,516

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-